T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.95B |
| 2 |
Broadcom
AVGO
|
$3.48B |
| 3 |
Microsoft
MSFT
|
$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
$1.92B |
| 5 |
GE Aerospace
GE
|
$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$2.63B |
| 3 |
Apple
AAPL
|
$2.46B |
| 4 |
Fiserv
FI
|
$2.19B |
| 5 |
Eli Lilly
LLY
|
$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Loews
L
$20B
| $335M | 0.04% |
3,655,053
-485,578
| -12% | -$44.5M |
|
327
Lazard
LAZ
$5.32B
| $332M | 0.04% |
6,923,540
+824,361
| +14% | +$39.6M |
|
|
SOBO
328
South Bow Corporation
SOBO
$5.76B
| $332M | 0.04% |
12,816,300
+199,157
| +2% | +$5.16M |
|
329
DocuSign
DOCU
$16.1B
| $330M | 0.04% |
4,230,941
+1,065,980
| +34% | +$83M |
|
330
RPM International
RPM
$16.2B
| $329M | 0.04% |
2,997,320
-135,135
| -4% | -$14.8M |
|
331
Marvell Technology
MRVL
$54.6B
| $329M | 0.04% |
4,251,421
+2,749,511
| +183% | +$213M |
|
332
Owens Corning
OC
$13B
| $328M | 0.04% |
2,387,530
+7,407
| +0.3% | +$1.02M |
|
333
Marqeta
MQ
$2.76B
| $328M | 0.04% |
56,232,460
+15,135,287
| +37% | +$88.2M |
|
334
KE Holdings
BEKE
$22.4B
| $325M | 0.04% |
18,293,832
-18,383,749
| -50% | -$326M |
|
335
MACOM Technology Solutions
MTSI
$9.67B
| $324M | 0.04% |
2,261,778
-924,197
| -29% | -$132M |
|
336
Ascendis Pharma
ASND
$12.5B
| $324M | 0.04% |
1,875,491
-380,611
| -17% | -$65.7M |
|
337
DuPont de Nemours
DD
$32.6B
| $321M | 0.04% |
4,685,650
+525,843
| +13% | +$36.1M |
|
338
Nike
NKE
$109B
| $320M | 0.04% |
4,499,406
+614,040
| +16% | +$43.6M |
|
339
Amgen
AMGN
$153B
| $319M | 0.04% |
1,142,525
-895,054
| -44% | -$250M |
|
340
Coinbase
COIN
$76.8B
| $317M | 0.04% |
905,305
+103,076
| +13% | +$36.1M |
|
341
T. Rowe Price Growth ETF
TGRT
$832M
| $316M | 0.04% |
7,819,264
+1,027,195
| +15% | +$41.5M |
|
342
Willis Towers Watson
WTW
$32.1B
| $312M | 0.04% |
1,019,506
+834,093
| +450% | +$256M |
|
343
Scholar Rock
SRRK
$3.02B
| $310M | 0.04% |
8,761,650
-132,236
| -1% | -$4.68M |
|
344
GSK
GSK
$81.5B
| $309M | 0.04% |
8,046,392
+324,078
| +4% | +$12.4M |
|
|
HES
345
DELISTED
Hess
HES
| $308M | 0.03% |
2,224,364
+180,876
| +9% | +$25.1M |
|
346
Avidity Biosciences
RNA
$6.48B
| $307M | 0.03% |
10,808,727
-529,371
| -5% | -$15M |
|
|
SARO
347
StandardAero, Inc.
SARO
$8.88B
| $307M | 0.03% |
9,690,365
+4,574,708
| +89% | +$145M |
|
348
Verra Mobility
VRRM
$3.97B
| $307M | 0.03% |
12,072,023
+1,806,675
| +18% | +$45.9M |
|
349
Vertiv
VRT
$47.4B
| $305M | 0.03% |
2,377,723
+1,434,106
| +152% | +$184M |
|
350
Vornado Realty Trust
VNO
$7.93B
| $301M | 0.03% |
7,871,715
+445,878
| +6% | +$17.1M |
|